mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
Nutlin-3 |
CCLE |
pan-cancer |
AAC |
0.021 |
0.7 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |